Karo Pharma’s SEK 2.5 Billion Rights Issue

White & Case has advised Karo Pharma AB on the deal.Karo Pharma AB executed its fully underwritten SEK 2.5 billion (approximately US$260 million) rights issue. The…

This content is for members only.
Login to Read More Join Now
Laura Testa

Author: Laura Testa

This content is for members only.
Login to Read More Join Now